Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway
Sepsis is a leading cause of death in patients with severe infection worldwide. Remifentanil is an ultra-short-acting, potent opioid analgesic. In the study, we aimed to investigate the role and underlying mechanism of remifentanil in lipopolysaccharide- (LPS-) induced inflammation in human aortic e...
Saved in:
| Main Authors: | Jian-ning Zhang, Yang Ma, Xi-yan Wei, Ke-yin Liu, Hao Wang, Hui Han, Yi Cui, Ming-xiang Zhang, Wei-dong Qin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2019/3013716 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selenium Yeast Attenuated Lipopolysaccharide-Induced Inflammation in Porcine Mammary Epithelial Cells by Modulating MAPK and NF-κB Signaling Pathways
by: Zhenting He, et al.
Published: (2025-03-01) -
Syndecan-3 inhibits lipopolysaccharide-induced inflammation of bovine mammary epithelial cells through the NF-κB signal transduction pathway
by: Haibin Yu, et al.
Published: (2024-12-01) -
Epigallocatechin Gallate Alleviates Lipopolysaccharide-Induced Intestinal Inflammation in Wenchang Chicken by Inhibiting the TLR4/MyD88/NF-κB Signaling Pathway
by: Xin Xu, et al.
Published: (2025-03-01) -
The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway
by: Jing Liu, et al.
Published: (2025-03-01) -
Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling
by: Yuanyuan Hou, et al.
Published: (2021-01-01)